Related Experiment Video
Updated: Jan 31, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Expression of p14ARF overcomes tumor resistance to p53
Wenge Lu1, Jiayuh Lin, Jiandong Chen
1Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.
Abstract:
Tumors without p53 mutation are often resistant to p53 gene therapy. We examined the mechanism using p53-resistant A549 cells and p53-sensitive H1299 cells. We found that p53 delivered by adenovirus is poorly expressed in A549 (ARF-null) cells but efficiently expressed in H1299 cells (ARF-positive). Strong p53 expression and apoptosis can be achieved in A549 cells using a p53 mutant resistant to degradation by MDM2 or by coexpression of ARF. The results suggest that enhanced MDM2 activity attributable to loss of ARF contributes to p53 resistance. Surprisingly, tumor cell lines with MDM2 gene amplification are still deficient for ARF expression, suggesting that MDM2 amplification does not substitute for ARF inactivation during tumor development.
Insights
Tumors resistant to p53 gene therapy may have enhanced MDM2 activity due to ARF loss. Restoring ARF or using a stabilized p53 mutant can overcome this resistance in cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Therapy
Background:
- Tumor cells lacking p53 mutations often exhibit resistance to p53 gene therapy.
- Understanding the mechanisms of this resistance is crucial for developing effective cancer treatments.
Purpose of the Study:
- To investigate the mechanisms underlying p53 gene therapy resistance in tumors.
- To identify strategies for overcoming p53 resistance in cancer cells.
Main Methods:
- Utilized p53-resistant A549 (ARF-null) and p53-sensitive H1299 (ARF-positive) cell lines.
- Employed adenovirus-mediated delivery of p53.
- Assessed p53 expression, MDM2 activity, ARF status, and apoptosis induction.
Main Results:
- Adenovirus-delivered p53 showed poor expression in ARF-null A549 cells but efficient expression in ARF-positive H1299 cells.
- Restoring p53 expression and apoptosis in A549 cells was achieved by using a p53 mutant resistant to MDM2 degradation or by co-expressing ARF.
- Loss of ARF was linked to enhanced MDM2 activity, contributing to p53 resistance.
Conclusions:
- Enhanced MDM2 activity, resulting from ARF loss, is a key mechanism of p53 resistance in tumors.
- ARF deficiency, not solely MDM2 amplification, appears critical for tumor development in the context of p53 resistance.
- Strategies targeting MDM2 or restoring ARF hold promise for enhancing p53 gene therapy efficacy.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...

